NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: M
Post# of 174
(Total Views: 166)
Posted On: 09/03/2020 3:35:16 PM
NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Delivers Crucial PPE, Drives Increased Revenues in Q2 2020
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, achieved a record $6.6 million in revenues for the second quarter of 2020, representing a 244% increase compared to the same period last year. In large part, the company attributes the boost to a critical and opportune strategy. A recent article discussing this reads, “Trxade’s large revenue increase was primarily due to its ability to deliver personal protective equipment (“PPE”) at a crucial time when the pandemic was provoking a worldwide scramble to keep workers safe and businesses’ doors open to their customer bases. While the PPE-related revenue boost is unlikely to be sustainable at such a high percentage as the surprise of the pandemic’s emergence wears off, analysts have noted that Trxade’s strategy has kept it on a steady footing with a stable balance sheet, low debt and wide market penetration.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, achieved a record $6.6 million in revenues for the second quarter of 2020, representing a 244% increase compared to the same period last year. In large part, the company attributes the boost to a critical and opportune strategy. A recent article discussing this reads, “Trxade’s large revenue increase was primarily due to its ability to deliver personal protective equipment (“PPE”) at a crucial time when the pandemic was provoking a worldwide scramble to keep workers safe and businesses’ doors open to their customer bases. While the PPE-related revenue boost is unlikely to be sustainable at such a high percentage as the surprise of the pandemic’s emergence wears off, analysts have noted that Trxade’s strategy has kept it on a steady footing with a stable balance sheet, low debt and wide market penetration.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Scienture Holdings, Inc. (SCNX) Stock Research Links
Scroll down for more posts ▼